HYALURONIC ACID: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Hyaluronic acid is a natural substance found in the fluids in the eyes and joints. It acts as a cushion and lubricant in the joints and other tissues.

Different forms of hyaluronic acid are used for cosmetic purposes. Hyaluronic acid might also affect the way the body responds to injury and help to decrease swelling.

People also commonly take hyaluronic acid by mouth and apply it to the skin for UTIs, acid reflux, dry eyes, wound healing, aging skin, and many other conditions, but there is no good scientific evidence to support most of these other uses.

Uses & Effectiveness

Possibly Effective for

Dry eye. Using eye drops containing hyaluronic acid seems to help relieve dry eye symptoms.
Leg sores caused by weak blood circulation (venous leg ulcer). Using a gauze containing hyaluronic acid seems to reduce the size of sores and promote healing.

There is interest in using hyaluronic acid for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.

Side Effects

When taken by mouth: Hyaluronic acid is likely safe when used appropriately. Allergic reactions might occur but are rare.

When applied to the skin: Hyaluronic acid is likely safe when used appropriately. Allergic reactions might occur but are rare.

Special Precautions and Warnings

Pregnancy: There isn't enough reliable information to know if hyaluronic acid is safe to use when pregnant. Stay on the safe side and avoid use.

Breast-feeding: There isn't enough reliable information to know if hyaluronic acid is safe to use when breast-feeding. It's not clear if it's excreted in breast milk and what effect that might have on an infant. Stay on the safe side and avoid use.

Radiation therapy: Applying hyaluronic acid to the skin while receiving radiation therapy might increase the risk of some skin complications. If you are receiving radiation therapy, don't use hyaluronic acid on your skin.

Hardening of skin and connective tissue (scleroderma): Applying hyaluronic acid to the skin might make skin ulcers worse in people who have a condition called scleroderma. If you have scleroderma, don't use hyaluronic acid on your skin.

Interactions

We currently have no information for HYALURONIC ACID overview.

Dosing

Hyaluronic acid is available in many different types of topical products, including creams, gels, mouthwashes, and eye drops. In supplements, there isn't enough reliable information to know what an appropriate dose of hyaluronic acid might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.

View References

REFERENCES:

Capurso A, Resta F, Ciancia D, Lavezzari M, Mogavero AM, Taverniti R, Di TM, Siciliani G, and Palmisano S. Effect of acipimox and pantethine on serum lipids and apoproteins in patients with type II hyperlipoproteinemia. Current Therapeutic Research 1987;42(6):1216-1222.

Cattin L, DaCol P Fonda M Mameli M Pilotto L Vanuzzo D et al. Treatment of hypercholesterolemia with pantethine and fenofibrate: an open randomized study on 43 subjects. Curr Ther Res 1985;38:386-395.

Cattin, L., Da Col, P. G., Fonda, M., Mameli, M. G., and Fergulio, G. A. Treatment of hypercholesterolemia with pantethine and fenofibrate; open randomized study on 43 subjects. Current Therapeutic Research 1985;38(Sep):386-395.

Coronel, F., Tornero, F., Torrente, J., Naranjo, P., De Oleo, P., Macia, M., and Barrientos, A. Treatment of hyperlipemia in diabetic patients on dialysis with a physiological substance. Am.J.Nephrol. 1991;11(1):32-36.

Da Col P, Cattin L Fonda M Mameli M Feruglio F. Pantethine in the treatment of hypercholesterolemia: a randomized double-blind trial versus tiadenol. Curr Ther Res 1984;36:214-221.

Da Col, P. G., Cattin, L., Fonda, M., and et al. Pantethine in the treatment of hypercholesterolemia: a randomized double-blind trial versus tiadenol. Current Therapeutic Research 1984;38:719-727.

Donati, C., Bertieri, R. S., and Barbi, G. [Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients]. Clin.Ter. 3-31-1989;128(6):411-422. View abstract.

Eto, M., Watanabe, K., Chonan, N., and Ishii, K. Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus. Artery 1987;15(1):1-12. View abstract.

Galeone F, Scalabrino A Giuntoli F Birindelli A Panigada G Rossi A et al. The lipid lowering effect of pantethine in hyperlipidemic patients: a clinical investigation. Curr Ther Res 1983;34:383-390.

Gensini, G. F., Prisco, D., Rogasi, P. G., Matucci, M., and Neri Serneri, G. G. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment. Int.J.Clin.Pharmacol.Res. 1985;5(5):309-318. View abstract.

Giannini S, Forti N DiRienzo F Campanari J Ziliotto E. Efeitos da pantetina sobrelipides sangineos. ArqBras Cardiol 1986;46:283-289.

Gleeson, J. M., Wittwer, C. T., Schipke, C. A., and Wilson, D. E. Effect of carnitine and pantethine on the metabolic abnormalities of acquired total lipodystrophy. Current Therapeutic Research 1987;41(Jan):83-88.

Hiramatsu, K., Nozaki, H., and Arimori, S. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia. Tokai J.Exp.Clin.Med. 1981;6(1):49-57. View abstract.

Ishihara, M., Iihara, H., Okayasu, S., Yasuda, K., Matsuura, K., Suzui, M., and Itoh, Y. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients. Support.Care Cancer 2010;18(12):1531-1538. View abstract.

Lu, Z. L. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1989;17(4):221-223. View abstract.

Maggi, G. C., Donati, C., and Criscuoli, G. Pantethine: physiological lipomodulating agent, in the treatment of hyperlipidemias. Current Therapeutic Research 1982;32(Sep):380-386.

Maioli M, Pacifico A Cherchi G. Effect of pantethine on the subfractions of HDL in dyslipidemic patients. Curr Ther Res 1984;35:307-311.

Maioli, M., Pacifico, A., and Cherchi, G. M. Effect of pantethine on the subfractions of HDL in dislipidemic patients. Current Therapeutic Research 1984;35(Feb):307-311.

McRae MP. Treatment of hyperlipoproteinemia with pantethine: A review and analysis of efficacy and tolerability. Nutrition Res 2005;25:319-333.

Miccoli R, Marchetti P Sampietro T Benzi L Tognarelli M Navalesi R. Effects of pantethine on lipids and apolipoproteins in hypercholesterolemic diabetic and non-diabetic patients. Curr Ther Res 1984;36:545-549.

Nomura, H., Kimura, Y., Okamoto, O., and Shiraishi, G. Effects of antihyperlipidemic drugs and diet plus exercise therapy in the treatment of patients with moderate hypercholesterolemia. Clin.Ther. 1996;18(3):477-482. View abstract.

Osono, Y., Hirose, N., Nakajima, K., and Hata, Y. The effects of pantethine on fatty liver and fat distribution. J.Atheroscler.Thromb. 2000;7(1):55-58. View abstract.

Penet, M. F., Abou-Hamdan, M., Coltel, N., Cornille, E., Grau, G. E., de, Reggi M., and Gharib, B. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc.Natl.Acad.Sci.U.S.A 1-29-2008;105(4):1321-1326. View abstract.

Pocecco, M. Treatment of infantile nephropathic cystinosis with cysteamine: 2. New England Journal of Medicine 1986;314(May 15):1320.

Postiglione, A., Rubba, P., Cicerano, U., Chierchia, I., and Mancini, M. Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia. Monogr Atheroscler. 1985;13:145-148. View abstract.

Rubba, P., Postiglione, A., De Simone, B., Lamenza, F., and Mancini, M. Comparative evaluation of the lipid-lowering effects of fenofibrate and pantethine in type II hyperlipoproteinemia. Current Therapeutic Research 1985;38(May):719-727.

Rumberger, J. A., Napolitano, J., Azumano, I., Kamiya, T., and Evans, M. Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation. Nutr.Res. 2011;31(8):608-615. View abstract.

Seghieri, G., Maffucci, G., Toscano, G., Santoni, F., Tuci, S., and De Giorgio, L. A. [Effect of pantethine therapy in chronic uremic patients undergoing hemodialysis with type IV hyperlipoproteinemia]. G.Clin.Med. 1985;66(5-6):187-192. View abstract.

Tonutti, L., Taboga, C., and Noacco, C. [Comparison of the efficacy of pantethine, acipimox, and bezafibrate on plasma lipids and index of cardiovascular risk in diabetics with dyslipidemia]. Minerva Med. 1991;82(10):657-663. View abstract.

Vignola, D., Fanini, A., and Biffignandi, P. [Effects of D(+)-bis-(N-pantothenyl-amidoethyl)-disulphur on the blood lipid profile and apoproteins A and B levels]. Clin.Ter. 6-30-1985;113(6):479-483. View abstract.

Wittwer, C. T., Gahl, W. A., Butler, J. D., Zatz, M., and Thoene, J. G. Metabolism of pantethine in cystinosis. J.Clin.Invest 1985;76(4):1665-1672. View abstract.

Agrati AM, Ambrosi G, Ferraro G, Palmieri. Gemfibrozil efficacy vs pantethine in dyslipoproteinemic patients: a controlled study. Curr Ther Res 1989;45:650-63.

Angelica M, Pinto G, Ciaccheri C, et al. Improvement in serum lipid profile in hyperlipoproteinemia patients after treatment with pantethine: a cross-over double-blind trial versus placebo. Curr Ther Res 1983;33:1091-7.

Anonymous. Pantethine. Altern Med Rev 1998;3:379-81.

Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Clin Ther 1986;8:537-45.. View abstract.

Bon GB, Cazzolato G, Zago S, et al. Effects of pantethine on in-vitro peroxidation of low density lipoproteins. Atherosclerosis 1985;57:99-106.. View abstract.

Butler JD, Zatz M. Pantethine depletes cystinotic fibroblasts of cystine. J Pediatr 1983;102:796-8.

Carrara P, Matturri L, Galbussera M, et al. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits. Atherosclerosis 1984;53:255-64. View abstract.

Chang X, Zhang J, Jiang Y, Yao B, Wang J, Wu Y. Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study. Orphanet J Rare Dis. 2020;15(1):248. View abstract.

Chen YQ, Zhao SP, Zhao YH. Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study. J Clin Lipidol. 2015;9(5):692-7. View abstract.

Cighetti G, Del Puppo M, Paroni R, Galli Kienle M. Modulation of HMG-CoA reductase activity by pantetheine/pantethine. Biochim Biophys Acta 1988;963:389-93. View abstract.

Clark JI, Livesey JC, Steele JE. Delay or inhibition of rat lens opacification using pantethine and WR-77913. Exp Eye Res 1996;62:75-84. View abstract.

Congdon NT, West ST, Duncan DT, et al. The effect of pantethine and ultraviolet-B radiation on the development of lenticular opacity in the emory mouse. Curr Eye Res 2000;20:17-24. View abstract.

Coronel F, Tornero F, Torrente J, et al. Treatment of hyperlipemia in diabetic patients on dialysis with a physiological substance. Am J Nephrol 1991;11:32-6.. View abstract.

Da Col PG, Cattin L, Fonda M, et al. Pantethine in the treatment of hypercholesterolemia: a randomized double-blind trial versus tiadenol. Curr Ther Res 1984;36:314-22.

Donati C, Barbi G, Cairo G, et al. Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial. Clin Nephrol 1986;25:70-4.. View abstract.

Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation. Vasc Health Risk Manag. 2014;10:89-100. View abstract.

Gaddi A, Descovich GC, Noseda G, et al. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. Atherosclerosis 1984;50:73-83. View abstract.

Hiraoka T, Clark JI, LI XY, Thurston GM. Effect of selected anti-cataract agents on opacification in the selenite cataract model. Exp Eye Res 1996;62:11-9. View abstract.

Kelly GS. Nutritional and botanical interventions to assist with the adaptation to stress. Altern Med Rev 1999;4:249-65.. View abstract.

Maggi GC, Donati C, Criscuoli G. Pantethine: a physiological lipomodulating agent in the treatment of hyperlipidemias. Curr Ther Res 1982;32:380-6.

Baker, C. L., Jr. and Ferguson, C. M. Future treatment of osteoarthritis. Orthopedics 2005;28(2 Suppl):s227-s234. View abstract.

de, Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast.Surg. 2004;28(5):295-300. View abstract.

Holmes and et al. Hyaluronic acid in human articular cartilage: Age-related changes in content and size. Biochem.J 1988;250:435-441.

Kalman, D. S., Heimer, M., Valdeon, A., Schwartz, H., and Sheldon, E. Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial. Nutr J 2008;7:3. View abstract.

Laurent, T. C., Dahl, I. M., Dahl, L. B., Engstrom-Laurent, A., Eriksson, S., Fraser, J. R., Granath, K. A., Laurent, C., Laurent, U. B., Lilja, K., and . The catabolic fate of hyaluronic acid. Connect.Tissue Res 1986;15(1-2):33-41. View abstract.

Lupo, M. P., Smith, S. R., Thomas, J. A., Murphy, D. K., and Beddingfield, F. C., III. Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast.Reconstr.Surg. 2008;121(1):289-297. View abstract.

Paker, N., Tekdos, D., Kesiktas, N., and Soy, D. Comparison of the therapeutic efficacy of TENS versus intra-articular hyaluronic acid injection in patients with knee osteoarthritis: a prospective randomized study. Adv.Ther. 2006;23(2):342-353. View abstract.

Petrella, R. J. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys.Med Rehabil. 2005;84(4):278-283. View abstract.

Rohrich, R. J., Ghavami, A., and Crosby, M. A. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast.Reconstr.Surg. 2007;120(6 Suppl):41S-54S. View abstract.

Smith, K. C. Practical use of Juvederm: early experience. Plast.Reconstr.Surg. 2007;120(6 Suppl):67S-73S. View abstract.

Uthman, I., Raynauld, J. P., and Haraoui, B. Intra-articular therapy in osteoarthritis. Postgrad.Med J 2003;79(934):449-453. View abstract.

97888 Torretta S, Marchisio P, Rinaldi V, et al. Topical administration of hyaluronic acid in children with recurrent or chronic middle ear inflammations. Int J Immunopathol Pharmacol. 2016;29(3):438-42. View abstract.

Abdulkareem AA, Al Marah ZA, Abdulbaqi HR, Alshaeli AJ, Milward MR. A randomized double-blind clinical trial to evaluate the efficacy of chlorhexidine, antioxidant, and hyaluronic acid mouthwashes in the management of biofilm-induced gingivitis. Int J Dent Hyg. 2020;18(3):268-277. View abstract.

Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25:2203-12. View abstract.

Altman RD. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin Arthritis Rheum 2000;30(2 Suppl 1):11-8. View abstract.

Aragona P, Benítez-Del-Castillo JM, Coroneo MT, et al. Safety and efficacy of a preservative-free artificial tear containing carboxymethylcellulose and hyaluronic acid for dry eye disease: A randomized, controlled, multicenter 3-month study. Clin Ophthalmol. 2020;14:2951-2963. View abstract.

Bardellini E, Amadori F, Schumacher RF, D'Ippolito C, Porta F, Majorana A. Efficacy of a solution composed by verbascoside, polyvinylpyrrolidone (PVP) and sodium hyaluronate in the treatment of chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2016;38(7):559-62. View abstract.

Belalcázar-Rey S, Sánchez Huerta V, Ochoa-Tabares JC, et al. Efficacy and safety of sodium hyaluronate/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: A clinical trial. Curr Eye Res. 2020:1-11. View abstract.

Boccalari E, Tadakamadla SK, Occhipinti C, Lanteri V, Maspero C. Evaluation of the effectiveness of a novel mouth rinse containing hyaluronic acid and hydrogen peroxide on gingivitis: a randomized pilot controlled trial. Clin Exp Dent Res 2022;8(3):673-9. View abstract.

Cagnacci A, Barattini DF, Casolati E, Pecoroni A, Mangrella M, Patrascu LC. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol 2022;270:239-45. View abstract.

Calonge M, Sahyoun M, Baillif S, et al. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease. Eur J Ophthalmol 2023;33(1):188-95. View abstract.

Campanati A, De Blasio S, Giuliano A, et al. Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial. Burns 2013;39(6):1178-83. View abstract.

Chen CP, Hung W, Lin SH. Effectiveness of hyaluronic acid for treating diabetic foot: a systematic review and meta-analysis. Dermatol Ther. 2014;27(6):331-6. View abstract.

Stamper RL, DiLoreto D, Schacknow P. Effect of intraocular aspiration of sodium hyaluronate on postoperative intraocular pressure. Ophthalmic Surg. 1990;21:486-91. View abstract.

Torella M, Del Deo F, Grimaldi A, et al. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125-128. View abstract.

U.S. Food and Drug Administration. Do Not Use Needle-Free Devices for Injection of Dermal Fillers - FDA Safety Communication. October 8, 2021. Available at: https://www.fda.gov/medical-devices/safety-communications/do-not-use-needle-free-devices-injection-dermal-fillers-fda-safety-communication. Accessed June 28, 2022.

Voigt J., Driver VR. Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: a systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2012;20(3):317-31. View abstract.

von Tirpitz C, Klaus J, Bruckel J, et al. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2000;12:19-24.. View abstract.

Wei M, Zou Y, Duan F, et al. Efficacy of Long-term Use of 0.3% Sodium Hyaluronate Eye Drops for Traumatic Corneal Abrasion: A Randomized Controlled, Pilot Trial. Cornea 2021;40(10):1248-1252. View abstract.

Yang YJ, Lee WY, Kim YJ, Hong YP. A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. Int J Environ Res Public Health 2021;18(5):2383. View abstract.

Yang Z, Li M, Xiao L, Yi Z, Zhao M, Ma S. Hyaluronic acid versus dexamethasone for the treatment of recurrent aphthous stomatitis in children: efficacy and safety analysis. Braz J Med Biol Res. 2020;53(8):e9886. View abstract.

What to Know About Snap-in Dentures

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.

HYALURONIC ACID - Uses, Side Effects, and More